HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by volume Browse by article Published Ahead
of Print
 

 

 

If you want to download the article, please login or register as reader.

2020

Heroin Addiction and Related Clinical Problems: 2020, 22, N1 (pages: 5 - 6)

Writer's Block Due to Pharmacokinetic Interaction

Zullino D., and Penzenstadler L.

Heroin Addiction and Related Clinical Problems: 2020, 22, N1 (pages: 7 - 8)

Mood Stabilizing Effects of Methadone in Opioid Use Disorder Patient

Gohari J., and Riaz U.

Heroin Addiction and Related Clinical Problems: 2020, 22, N1 (pages: 9 - 16)

The impact of affective temperaments on opioid dependence and addiction severity

Inanli I., Ozturk H.I., Caliskan A.M., Ozbek S., Demirel B., Er M., and Eren I.

Heroin Addiction and Related Clinical Problems: 2020, 22, N1 (pages: 17 - 22)

Stigma against pregnant women addicted to opioids with a case report

Mehić-Basara N., Marjanović-Lisac S., and Grabovica M.

Heroin Addiction and Related Clinical Problems: 2020, 22, N1 (pages: 23 - 30)

High prevalence and risks factors for non-communicable diseases in older people with opioid use disorder.

Vallecillo G., Robles M.J., Duran X., Castillo C., Fonseca F., and Torrens M.

Heroin Addiction and Related Clinical Problems: 2020, 22, N1 (pages: 31 - 40)

Is the Treatment Long Enough? Associations Between Quality of Life and Treatment Duration in Methadone Maintenance Treatment

Chen Y.-A., Yen T.-T., Hsu W.-Y., Chang T.-G., Chang Y.-J., Chiu N.-Y., and Chang C.-C.

Heroin Addiction and Related Clinical Problems: 2020, 22, N1 (pages: 41 - 48)

Nearly thirty years of experience of real-world long-term treatment with Opioid Agonists

Lamanna F., Maremmani A.G.I., and Maremmani I.

Heroin Addiction and Related Clinical Problems: 2020, 22, N2 (pages: 5 - 14)

Mapping service user needs to inform a supervised Injecting room location in Cork, Ireland, EU

Horan J.A., and Van Hout M.C.

Heroin Addiction and Related Clinical Problems: 2020, 22, N2 (pages: 15 - 22)

Is there a correlation between vitamin D deficiency and low serum level of GDNF in substance use disorder cases?

Alipour M., Jafarian M., Mokri A., Gorji A., Zarindast M.R., Kargar Kheirabad A., and Razaghi E.M.

Heroin Addiction and Related Clinical Problems: 2020, 22, N2 (pages: 23 - 28)

Buprenorphine for the treatment of alcohol dependence: 14 attempts, 3 successful cases

Ulmer A., and Meinhold C.

Heroin Addiction and Related Clinical Problems: 2020, 22, N2 (pages: 29 - 34)

Assessing the Medical and Psychological Problems Faced by ‘Majun-e-falak Sair' Addicts

Jan S.U.K., Ali A., and Asad A.Z.

Heroin Addiction and Related Clinical Problems: 2020, 22, N2 (pages: 35 - 43)

A prospective study of psychopathology stability and changes after 3-month residential treatment in Italian Substance Use Disorder patients

Maremmani I., Iantomasi C., Pani P.P., Maremmani A.G.I., and Mathis F. for the VOECT Group

Heroin Addiction and Related Clinical Problems: 2020, 22, N3 (pages: 5 - 11)

Hepatitis C Related Mortality in a Cohort of Drug Users in Flanders

De Ryck H., and Matheï C.

Heroin Addiction and Related Clinical Problems: 2020, 22, N3 (pages: 13 - 19)

Extent and Trend of Prescription Opioids in Assisted Treatment Programmes for Opioid Addiction and Pain Medications in Slovenia from 2007 until 2018

Kostnapfel T., Korosec A., and Kastelic A.

Heroin Addiction and Related Clinical Problems: 2020, 22, N3 (pages: 21 - 30)

Children's Psychological Well-Being, Anxiety, Depression, and Stress: The Role of Addicted and Non-Addicted Parents

Moeenizadeh M., Anbarani B., and Asghari Ebrahimabad M.J.

Heroin Addiction and Related Clinical Problems: 2020, 22, N3 (pages: 31 - 36)

Association of Serum Leptin Level with Body Mass Index and Lipid Profile in Diacetylmorphine (Heroine) Addicts Versus Healthy Controls.

Habib S.H., Khizar S.H., Malik M.O., Tariq M., Ramzan M.H., and Khan M.K.

Heroin Addiction and Related Clinical Problems: 2020, 22, N3 (pages: 37 - 48)

Prominent Psychopathological and Clinical Characteristics of Heroin Post-Traumatic Stress Disorder Spectrum Patients During Treatment

Maremmani I., Cecchini L., Avella M.T., Novi M., Ciapparelli A., and Maremmani A.G.I.

Heroin Addiction and Related Clinical Problems: 2020, 22, N4 (pages: 5 - 14)

Dermatological and Psychiatric Manifestations in Heroin and Bonsai Use Disorder

Can Y., Kıvanç Altunay İ., Mercan S., Evren C., Poşpoş Ö.H., and Özkur E.

Heroin Addiction and Related Clinical Problems: 2020, 22, N4 (pages: 15 - 22)

Medical Adjustment of Alcohol Dependence – a Comparison of Treatment Results with Dihydrocodeine and Acamprosate

Ulmer A., Frietsch B., and Mueller M.

Heroin Addiction and Related Clinical Problems: 2020, 22, N4 (pages: 23 - 27)

Frequency Rate of Violence and Contributing Factors in Methadone Maintenance Treatment Centers in Tehran, Iran

Kheradmand A., Iliaiee S., Ghafari Nejad A., and Mashayekhi M.M.

Heroin Addiction and Related Clinical Problems: 2020, 22, N4 (pages: 29 - 38)

Harm Reduction 24/7: Evaluation of the Vending Machine Program for Drug Users in North Rhine-Westphalia, Germany.

Deimel D., Felix O., Bock C., and Stöver H.

Heroin Addiction and Related Clinical Problems: 2020, 22, N4 (pages: 39 - 47)

The Psychopathology Specific to Substance Use Disorder Is Able to Discriminate between Young People with and without Problematic Internet Use

Maremmani A.G.I., Cerniglia L., Cimino S., Maiello M., Della Rocca F., and Maremmani I.

Heroin Addiction and Related Clinical Problems: 2020, 22, N5 (pages: 5 - 11)

Can the Psychopathology Specific to Substance Use Disorder Distinguish between Reward and Relief Craving?

Maremmani A.G.I., Pallucchini A., Manni C., Cipollone G., Della Rocca F., Salarpi G., Perugi G., and Maremmani I.

Heroin Addiction and Related Clinical Problems: 2020, 22, N5 (pages: 13 - 18)

Tramadol as the Most Prescribed Opioid Analgetic Medication in Slovenia in Recent Years

Kostnapfel T., Korošec A., and Kastelic A.

Heroin Addiction and Related Clinical Problems: 2020, 22, N5 (pages: 19 - 27)

Sleep Quality in Heroin-Dependent Patients Undergoing Three Types of Maintenance Therapy: The Benefits Promised by Opium Tincture Maintenance Therapy

Hojjat S.K., Kaviyani F., Akbari H., and Norozi Khalili M.

Heroin Addiction and Related Clinical Problems: 2020, 22, N5 (pages: 29 - 39)

The TALS – Reduced Form: An Inventory for Assessing the Heroin Post-Traumatic Stress Disorder Spectrum (H/Ptsd-S)

Maremmani I., and Miccoli M.

Heroin Addiction and Related Clinical Problems: 2020, 22, N5 (pages: 41 - 45)

Depression Resistant to Antidepressant Medications or Depression Complicated by Hypophoria? A Case Report

Paganin W., Signorini S., and Maremmani I.

Heroin Addiction and Related Clinical Problems: 2020, 22, N5 (pages: 47 - 48)

Methadone as a Treatment Option for Restless Leg Syndrome in Opioid Use Disorder Patient.

Riaz U.

Heroin Addiction and Related Clinical Problems: 2020, 22, N6 (pages: 5 - 13)

"Bursting the Lyrica Bubble”: Experiences of Pregabalin Use in Individuals Accessing Opioid Agonist Treatment in Dublin, Ireland

Brennan R., and Van Hout M.C.

Heroin Addiction and Related Clinical Problems: 2020, 22, N6 (pages: 15 - 23)

The Association between Somatic Complaints and Past-30 Day Opioid Misuse among Justice-Involved Children

Johnson M.E., and Clerjuste S.

Heroin Addiction and Related Clinical Problems: 2020, 22, N6 (pages: 25 - 30)

Predicting Craving Beliefs through Abstinence Self-Efficacy Components

Farzin M.M., and Abed M.

Heroin Addiction and Related Clinical Problems: 2020, 22, N6 (pages: 31 - 38)

Anti-Hcv Treatment for Opiate Addicts: Clinical and Immunological Issues

Occhino G., Somaini L., Maremmani I., Maremmani A.G.I., Boccato E., Pirisi M., and Pacini M.

Heroin Addiction and Related Clinical Problems: 2020, 22, N6 (pages: 39 - 48)

Is the Non-Medical Use of Pregabalin Related to Reward/Relief Craving Coupled to an Unbalanced Opioid System?

Della Rocca F., Cosentino V., Carbone M.G., Maremmani A.G.I., and Maremmani I.

Heroin Addiction and Related Clinical Problems: 2020, 22, N6 (pages: 49 - 56)

Is the Psychopathology Specific of Substance Use Disorder Able to Differentiate Problematic and Non-Problematic Recreational Drinkers?

Pagni L., Conversano C., Miccoli M., Maremmani A.G.I., Pani P.P., and Maremmani I.

Heroin Addiction and Related Clinical Problems: 2020, 22, N6 (pages: 57 - 72)

Toward Patient-Tailored Therapy in Agonist Opioid Treatment: The Role of Psychopathology, Craving Behavioural Covariates, Stress Reaction and Methadone Blood Concentration. A Case Series

Maremmani A.G.I., Bacciardi S., Maremmani I., Della Rocca F., Lamanna F., Socci C., Cerrai E., Zallocco L., Cerniglia L., Cimino S., Giusti L., Lucacchini A., Protti M., Mercolini L., Perugi G., and Mazzoni M.R.

 

AU-CNS Associazione per l’Utilizzo delle Conoscenze Neuroscientifiche a fini Sociali
Association for the Application of Neuroscientific Knowledge to Social Aims
Via XX Settembre, 83 – 55045 PIETRASANTA (Lucca) - Italy
P. IVA 01681650469 – Codice Fiscale 94002580465 Reserved Area
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page